CAROT will assist investigators in the design, implementation, and validation of assays that can ultimately support development of a novel ophthalmic therapeutic. The nature of the target will determine the specific details of the assay. CAROT will also assist with generating timelines, budgets, developing protocols and planning data analyses for these assays. Guidelines will draw upon CAROT’s experience in assay development relevant to Phase 1-3 human ocular gene therapy clinical trials.
F.M. Kirby Center for Molecular Ophthalmology
Stellar-Chance Labs 309 & 807
422 Curie Blvd.
Philadelphia, PA 19104-6100
Fax: 215-573-7155
Media Inquiries
Leeann Donegan, Penn Medicine Communications
215-349-5660
Vector Core Research Inquiries
Junwei Sun
iPSC Core Facility Research Inquiries
Jeannette Bennicelli
Patient Inquiries
FAQ
The Center for Advanced Retinal and Ocular Therapeutics, or CAROT, is advancing the development of novel biologic and small molecule therapeutics for retinal and ocular diseases through a balanced commitment to basic research, translational development, and the clinician/patient communities.
Site Design: Squirrelle | Powered by: -melle.io- | © 2014-2017 Center for Advanced Retinal and Ocular Therapeutics